IMI offers Euro12 million for project on how to involve patients in drug development/evaluation decisions
This article was originally published in SRA
Executive Summary
In view of the growing consensus that the views of patients should be incorporated in drug development and evaluation decisions, the Innovative Medicines Initiative is offering €12 million in EU funding for a project to explore the specifics of this concept1,2.